{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T23:54:10Z","timestamp":1790294050457,"version":"4.1.0"},"reference-count":44,"publisher":"The Endocrine Society","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,7,1]]},"DOI":"10.1210\/jc.2008-2604","type":"journal-article","created":{"date-parts":[[2009,4,14]],"date-time":"2009-04-14T20:39:10Z","timestamp":1239741550000},"page":"2313-2320","source":"Crossref","is-referenced-by-count":62,"title":["Combined Transdermal Testosterone Gel and the Progestin Nestorone Suppresses Serum Gonadotropins in Men"],"prefix":"10.1210","volume":"94","author":[{"given":"Vahid","family":"Mahabadi","sequence":"first","affiliation":[{"name":"Department of Medicine (V.M., P.D.C., R.S.S., C.W.), Division of Endocrinology, Harbor-UCLA Medical Center and Los Angeles Biomedical Research Institute, Torrance, California 90509"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John K.","family":"Amory","sequence":"additional","affiliation":[{"name":"Department of Medicine (J.K.A., W.J.B., S.T.P.), University of Washington, Seattle, Washington 98195"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald S.","family":"Swerdloff","sequence":"additional","affiliation":[{"name":"Department of Medicine (V.M., P.D.C., R.S.S., C.W.), Division of Endocrinology, Harbor-UCLA Medical Center and Los Angeles Biomedical Research Institute, Torrance, California 90509"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William J.","family":"Bremner","sequence":"additional","affiliation":[{"name":"Department of Medicine (J.K.A., W.J.B., S.T.P.), University of Washington, Seattle, Washington 98195"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie T.","family":"Page","sequence":"additional","affiliation":[{"name":"Department of Medicine (J.K.A., W.J.B., S.T.P.), University of Washington, Seattle, Washington 98195"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Regine","family":"Sitruk-Ware","sequence":"additional","affiliation":[{"name":"Center for Biomedical Research (R.S.-W., N.K., Y.-Y.T.), Population Council, New York, New York 10021"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter D.","family":"Christensen","sequence":"additional","affiliation":[{"name":"Department of Medicine (V.M., P.D.C., R.S.S., C.W.), Division of Endocrinology, Harbor-UCLA Medical Center and Los Angeles Biomedical Research Institute, Torrance, California 90509"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Narender","family":"Kumar","sequence":"additional","affiliation":[{"name":"Center for Biomedical Research (R.S.-W., N.K., Y.-Y.T.), Population Council, New York, New York 10021"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun-Yen","family":"Tsong","sequence":"additional","affiliation":[{"name":"Center for Biomedical Research (R.S.-W., N.K., Y.-Y.T.), Population Council, New York, New York 10021"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Blithe","sequence":"additional","affiliation":[{"name":"Contraception and Reproductive Health Branch (D.B.), National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland 20852"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Medicine (V.M., P.D.C., R.S.S., C.W.), Division of Endocrinology, Harbor-UCLA Medical Center and Los Angeles Biomedical Research Institute, Torrance, California 90509"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","reference":[{"key":"key\n\t\t\t\t2019041113321250600_R1","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1210\/er.2007-0041","article-title":"Advances in male contraception.","volume":"29","author":"Page","year":"2008","journal-title":"Endocr Rev"},{"key":"key\n\t\t\t\t2019041113321250600_R2","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/S0140-6736(05)70774-1","article-title":"Hopes for male contraception.","volume":"365","author":"Nieschlag","year":"2005","journal-title":"Lancet"},{"key":"key\n\t\t\t\t2019041113321250600_R3","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.1210\/jc.2008-1007","article-title":"Male hormonal contraception: so near and yet so far.","volume":"93","author":"Liu","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113321250600_R4","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1210\/jc.2002-020447","article-title":"A multicenter contraceptive efficacy study of injectable testosterone undecanoate in healthy Chinese men.","volume":"88","author":"Gu","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113321250600_R5","doi-asserted-by":"crossref","first-page":"4659","DOI":"10.1210\/jc.2003-030107","article-title":"Contraceptive efficacy of a depot progestin and androgen combination in men.","volume":"88","author":"Turner","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113321250600_R6","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/0140-6736(90)92416-F","volume":"336","journal-title":"Lancet"},{"key":"key\n\t\t\t\t2019041113321250600_R7","first-page":"821","volume":"65","journal-title":"Fertil Steril [Erratum (1996) 65:1267]"},{"key":"key\n\t\t\t\t2019041113321250600_R8","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1210\/jc.2007-2768","article-title":"Determinants of the rate and extent of spermatogenic suppression during hormonal male contraception: an integrated analysis.","volume":"93","author":"Liu","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113321250600_R9","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1016\/S0140-6736(06)68614-5","article-title":"Rate, extent, and modifiers of spermatogenic recovery after hormonal male contraception: an integrated analysis.","volume":"367","author":"Liu","year":"2006","journal-title":"Lancet"},{"key":"key\n\t\t\t\t2019041113321250600_R10","first-page":"1326","article-title":"Suppression of human spermatogenesis by testosterone implants.","volume":"75","author":"Handelsman","year":"1992","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113321250600_R11","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1002\/j.1939-4640.2003.tb02695.x","article-title":"A review of androgen-progestin regimens for male contraception.","volume":"24","author":"Meriggiola","year":"2003","journal-title":"J Androl"},{"key":"key\n\t\t\t\t2019041113321250600_R12","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/S0039-128X(03)00135-1","article-title":"Use of progestins in male contraception.","volume":"68","author":"Nieschlag","year":"2003","journal-title":"Steroids"},{"key":"key\n\t\t\t\t2019041113321250600_R13","doi-asserted-by":"crossref","first-page":"S60","DOI":"10.1016\/j.ajog.2004.01.057","article-title":"Male hormonal contraception","volume":"190","author":"Wang","year":"2004","journal-title":"Am J Obstet Gynecol"},{"key":"key\n\t\t\t\t2019041113321250600_R14","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1210\/jc.2003-031307","article-title":"Male hormonal contraception: effects of injections of testosterone undecanoate and depot medroxyprogesterone acetate at eight-week intervals in Chinese men.","volume":"89","author":"Gu","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113321250600_R15","first-page":"4113","article-title":"Establishing the minimum effective dose and additive effects of depot progestin in suppression of human spermatogenesis by a testosterone depot.","volume":"81","author":"Handelsman","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113321250600_R16","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1046\/j.1365-2265.2000.01024.x","article-title":"Intramuscular testosterone undecanoate with or without oral levonorgestrel: a randomized placebo-controlled feasibility study for male contraception.","volume":"53","author":"Kamischke","year":"2000","journal-title":"Clin Endocrinol (Oxf)"},{"key":"key\n\t\t\t\t2019041113321250600_R17","first-page":"303","article-title":"Intramuscular testosterone undecanoate and norethisterone enanthate in a clinical trial for male contraception.","volume":"86","author":"Kamischke","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113321250600_R18","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1210\/jc.2004-1852","article-title":"Norethisterone enanthate plus testosterone undecanoate for male contraception: effects of various injection intervals on spermatogenesis, reproductive hormones, testis, and prostate.","volume":"90","author":"Meriggiola","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113321250600_R19","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1210\/jc.2005-1743","article-title":"Levonorgestrel implants enhanced the suppression of spermatogenesis by testosterone implants: comparison between Chinese and non-Chinese men.","volume":"91","author":"Wang","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113321250600_R20","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/S0015-0282(16)60623-4","article-title":"Suppression of sperm function by depot medroxyprogesterone acetate and testosterone enanthate in steroid male contraception.","volume":"51","author":"Wu","year":"1989","journal-title":"Fertil Steril"},{"key":"key\n\t\t\t\t2019041113321250600_R21","doi-asserted-by":"crossref","first-page":"2572","DOI":"10.1210\/jc.2008-0265","article-title":"Male hormonal contraception: a double-blind, placebo-controlled study.","volume":"93","author":"Mommers","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113321250600_R22","doi-asserted-by":"crossref","first-page":"4374","DOI":"10.1210\/jc.2006-1411","article-title":"Testosterone gel combined with depomedroxyprogesterone acetate is an effective male hormonal contraceptive regimen and is not enhanced by the addition of a GnRH antagonist.","volume":"91","author":"Page","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113321250600_R23","first-page":"1244","article-title":"Clinical trial of transdermal testosterone and oral levonorgestrel for male contraception.","volume":"84","author":"Buchter","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113321250600_R24","doi-asserted-by":"crossref","first-page":"3562","DOI":"10.1210\/jcem.87.8.8710","article-title":"Levonorgestrel implants (Norplant II) for male contraception clinical trials: combination with transdermal and injectable testosterone.","volume":"87","author":"Gonzalo","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113321250600_R25","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1210\/jc.2002-021058","article-title":"AA2500 testosterone gel normalizes androgen levels in aging males with improvements in body composition and sexual function.","volume":"88","author":"Steidle","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113321250600_R26","first-page":"4500","article-title":"Long-term pharmacokinetics of transdermal testosterone gel in hypogonadal men.","volume":"85","author":"Swerdloff","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113321250600_R27","first-page":"2839","article-title":"Transdermal testosterone gel improves sexual function, mood, muscle strength, and body composition parameters in hypogonadal men. Testosterone Gel Study Group.","volume":"85","author":"Wang","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113321250600_R28","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1210\/jc.2003-032006","article-title":"Long-term testosterone gel (AndroGel) treatment maintains beneficial effects on sexual function and mood, lean and fat mass, and bone mineral density in hypogonadal men.","volume":"89","author":"Wang","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113321250600_R29","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0039-128X(00)00119-7","article-title":"Nestorone: a progestin with a unique pharmacological profile.","volume":"65","author":"Kumar","year":"2000","journal-title":"Steroids"},{"key":"key\n\t\t\t\t2019041113321250600_R30","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S0039-128X(97)00005-6","article-title":"Synthesis and progestational activity of 16-methylene-17\u03b1-hydroxy-19-norpregn-4-ene-3,20-dione and its derivatives.","volume":"62","author":"Li","year":"1997","journal-title":"Steroids"},{"key":"key\n\t\t\t\t2019041113321250600_R31","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1093\/humupd\/dmi046","article-title":"New progestagens for contraceptive use.","volume":"12","author":"Sitruk-Ware","year":"2006","journal-title":"Hum Reprod Update"},{"key":"key\n\t\t\t\t2019041113321250600_R32","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.contraception.2004.12.015","article-title":"Serum Nestorone and ethinyl estradiol levels, and ovulation inhibition in women using three different dosage combinations of a Nestorone progestogen-ethinyl estradiol contraceptive vaginal ring on a bleeding-signaled regimen.","volume":"72","author":"Fraser","year":"2005","journal-title":"Contraception"},{"key":"key\n\t\t\t\t2019041113321250600_R33","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.contraception.2004.08.010","article-title":"Contraceptive vaginal rings releasing Nestorone and ethinylestradiol: a 1-year dose-finding trial.","volume":"71","author":"Sivin","year":"2005","journal-title":"Contraception"},{"key":"key\n\t\t\t\t2019041113321250600_R34","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.contraception.2007.08.006","article-title":"An initial pharmacokinetic study with a metered dose transdermal system for delivery of the progestogen Nestorone as a possible future contraceptive.","volume":"76","author":"Fraser","year":"2007","journal-title":"Contraception"},{"key":"key\n\t\t\t\t2019041113321250600_R35","year":"1999"},{"key":"key\n\t\t\t\t2019041113321250600_R36","doi-asserted-by":"crossref","first-page":"853","DOI":"10.2164\/jandrol.106.000281","article-title":"Pharmacokinetics of testosterone undecanoate injected alone or in combination with norethisterone enanthate in healthy men.","volume":"27","author":"Qoubaitary","year":"2006","journal-title":"J Androl"},{"key":"key\n\t\t\t\t2019041113321250600_R37","author":"Agresti","year":"2002"},{"key":"key\n\t\t\t\t2019041113321250600_R38","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1002\/j.1939-4640.2001.tb03445.x","article-title":"Daily testosterone and gonadotropin levels are similar in azoospermic and nonazoospermic normal men administered weekly testosterone: implications for male contraceptive development.","volume":"22","author":"Amory","year":"2001","journal-title":"J Androl"},{"key":"key\n\t\t\t\t2019041113321250600_R39","doi-asserted-by":"crossref","first-page":"405","DOI":"10.2164\/jandrol.04135","article-title":"Intramuscular testosterone enanthate plus very low dosage oral levonorgestrel suppresses spermatogenesis without causing weight gain in normal young men: a randomized clinical trial.","volume":"26","author":"Anawalt","year":"2005","journal-title":"J Androl"},{"key":"key\n\t\t\t\t2019041113321250600_R40","doi-asserted-by":"crossref","first-page":"362","DOI":"10.2164\/jandrol.106.002311","article-title":"10th Summit Meeting consensus: recommendations for regulatory approval for hormonal male contraception.","volume":"28","author":"Aaltonen","year":"2007","journal-title":"J Androl"},{"key":"key\n\t\t\t\t2019041113321250600_R41","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.maturitas.2004.01.001","article-title":"Pharmacological profile of progestins.","volume":"47","author":"Sitruk-Ware","year":"2004","journal-title":"Maturitas"},{"key":"key\n\t\t\t\t2019041113321250600_R42","doi-asserted-by":"crossref","first-page":"2936","DOI":"10.1210\/jc.2003-031802","article-title":"Testosterone metabolic clearance and production rates determined by stable isotope dilution\/tandem mass spectrometry in normal men: influence of ethnicity and age.","volume":"89","author":"Wang","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113321250600_R43","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1210\/er.2003-0005","article-title":"Androgens and cardiovascular disease.","volume":"24","author":"Liu","year":"2003","journal-title":"Endocr Rev"},{"key":"key\n\t\t\t\t2019041113321250600_R44","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1210\/er.2001-0025","article-title":"Androgens and coronary artery disease.","volume":"24","author":"Wu","year":"2003","journal-title":"Endocr Rev"}],"container-title":["The Journal of Clinical Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/94\/7\/2313\/9063921\/jcem2313.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,19]],"date-time":"2019-05-19T08:56:40Z","timestamp":1558256200000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/94\/7\/2313\/2596524"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,7,1]]},"references-count":44,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2009,7,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jc.2008-2604","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,7,1]]}}}